A Vanderbilt study found that renin-angiotensin-aldosterone system (RAASi) inhibitor drugs, which are commonly used to regulate high blood pressure, do not disproportionately increase the risk of acute kidney injury (AKI) in patients with COVID-19 compared to patients hospitalized with influenza.

Vanderbilt's Tom Talbot, MD, MPH, was recently elected to serve in the leadership of the Society for Healthcare Epidemiology of America.

Eric Austin, MD, MSCI, director of the Pediatric Pulmonary Hypertension Program at Monroe Carell Jr. Children’s Hospital at Vanderbilt, has been elected to the council of the Society for Pediatric Research.

Vanderbilt's extracorporeal life support fellowship gives new doctors two years of hands-on experience with a lifesaving critical care tool, one that has only become more important during the COVID-19 pandemic.

Vanderbilt's Don Moore, PhD, has received the Distinguished Service in Continuing Medical Education Award from the Society for Academic Continuing Medical Education.

A multidisciplinary team at Vanderbilt helped José Ontiveros cope with a long list of severe complications arising from his COVID-19i infection.

Bob Mangeot has been promoted to Vice President and Chief Compliance Officer at Vanderbilt University Medical Center, having served in the role on an interim basis since December.